Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection

Clinical and Experimental Immunology

Volumn 179, Issue 3, 2015, Pages 454-465

  Feruglio, S L ^a,b   Tonby, K ^a,c   Kvale, D ^a,c   Dyrhol Riise, A M ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytokines; T cells; Tregs; Treatment; Tuberculosis

Indexed keywords

CD147 ANTIGEN; CD161 ANTIGEN; CULTURE FILTRATE PROTEIN 10; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; ACYLTRANSFERASE; ANTIGEN 85A, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CFP-10 PROTEIN (71-85), MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; LEUKOCYTE ANTIGEN; PEPTIDE FRAGMENT; PHARMACOLOGICAL BIOMARKER;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUBERCULOSIS; CELL CULTURE; DRUG EFFECTS; FOLLOW UP; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; PHYSIOLOGIC MONITORING; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ACYLTRANSFERASES; ADULT; AGED; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BIOMARKERS, PHARMACOLOGICAL; CELLS, CULTURED; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84922800635     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12468     Document Type: Article

References (54)

1. World Health Organization (WHO). Global Tuberculosis Report. Geneva: WHO; 2013. WHO/HTM/TB/2013.13.
2. Wallis RS, Kim P, Cole S etal. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 2013; 13:362-372.
3. Gandhi NR, Nunn P, Dheda K etal. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375:1830-1843.
4. Dheda K, Schwander SK, Zhu B, Van Zyl-Smit RN, Zhang Y. The immunology of tuberculosis: from bench to bedside. Respirology 2010; 15:433-450.
5. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol 2013; 31:475-527.
6. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
7. Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol 2010; 161:1-9.
8. Lindenstrom T, Agger EM, Korsholm KS etal. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 2009; 182:8047-8055.
9. Scriba TJ, Tameris M, Mansoor N etal. Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol 2010; 40:279-290.
10. Harari A, Rozot V, Enders FB etal. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011; 17:372-376.
11. Caccamo N, Guggino G, Joosten SA etal. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010; 40:2211-2220.
12. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 2009; 39:723-729.
13. Larson RP, Shafiani S, Urdahl KB. Foxp3(+) regulatory T cells in tuberculosis. Adv Exp Med Biol 2013; 783:165-180.
14. Hougardy JM, Place S, Hildebrand M etal. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med 2007; 176:409-416.
15. Wergeland I, Assmus J, Dyrhol-Riise AM. T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy. Scand J Immunol 2011; 73:234-242.
16. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006; 173:803-810.
17. He XY, Xiao L, Chen HB etal. T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis 2010; 29:643-650.
18. Lamoreaux L, Roederer M, Koup R. Intracellular cytokine optimization and standard operating procedure. Nat Protoc 2006; 1:1507-1516.
19. Lovelace P, Maecker H. Multiparameter intracellular cytokine staining. In: Hawley TS, Hawley RG, eds. Flow cytometry protocols. New York: Humana Press, 2011:165-178.
20. Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011; 79A:167-174.
21. Liu W, Putnam AL, Xu-Yu Z etal. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006; 203:1701-1711.
22. Solstad T. CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells. Blood 2011; 118:5141-5151.
23. Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, Wedderburn LR. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood 2013; 121:2647-2658.
24. Chiacchio T, Casetti R, Butera O etal. Characterization of regulatory T cells identified as CD4+CD25highCD39+ in patients with active tuberculosis. Clin Exp Immunol 2009; 156:463-470.
25. Mattos AM, Almeida Cde S, Franken KL etal. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Int Immunol 2010; 22:775-782.
26. Veenstra H, Crous I, Brahmbhatt S etal. Changes in the kinetics of intracellular IFN-gamma production in TB patients during treatment. Clin Immunol 2007; 124:336-344.
27. Day CL, Abrahams DA, Lerumo L etal. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 2011; 187:2222-2232.
28. de Steenwinkel JE, de Knegt GJ, ten Kate MT, Verbrugh HA, Ottenhoff TH, Bakker-Woudenberg IA. Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy. Eur J Clin Microbiol Infect Dis 2012; 31:1195-1201.
29. den Hertog AL, de Vos AF, Klatser PR, Anthony RM. Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study. PLOS ONE 2013; 8:e57997.
30. Jackson-Sillah D, Cliff JM, Mensah GI etal. Recombinant ESAT-6-CFP10 fusion protein induction of Th1/Th2 cytokines and FoxP3 expressing Treg cells in pulmonary TB. PLOS ONE 2013; 8:e68121.
31. Chiappini E, Fossi F, Bonsignori F, Sollai S, Galli L, de Martino M. Utility of interferon-gamma release assay results to monitor anti-tubercular treatment in adults and children. Clin Ther 2012; 34:1041-1048.
32. Sester U, Fousse M, Dirks J etal. Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLOS ONE 2011; 6:e17813.
33. Streitz M, Fuhrmann S, Thomas D etal. The phenotypic distribution and functional profile of tuberculin-specific CD4 T-cells characterizes different stages of TB infection. Cytometry B Clin Cytom 2012; 82:360-368.
34. Petruccioli E, Petrone L, Vanini V etal. IFNgamma/TNFalpha specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 2013; 66:475-486.
35. Chiacchio T, Petruccioli E, Vanini V etal. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J Infect 2014. doi: 10.1016/j.jinf.2014.06.009. [Epub ahead of print].
36. Day CL, Mkhwanazi N, Reddy S etal. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J Infect Dis 2008; 197:990-999.
37. Millington KA, Innes JA, Hackforth S etal. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007; 178:5217-5226.
38. Young JM, Adetifa IM, Ota MO, Sutherland JS. Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment. PLOS ONE 2010; 5:e11237.
39. Ottenhoff TH. New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol 2012; 20:419-428.
40. Djoba Siawaya JF, Chegou NN, van den Heuvel MM etal. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine 2009; 47:132-136.
41. Betts MR, Brenchley JM, Price DA etal. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281:65-78.
42. Ritz N, Dutta B, Donath S etal. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Am J Respir Crit Care Med 2012; 185:213-222.
43. Mueller H, Fae KC, Magdorf K etal. Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence. PLOS ONE 2011; 6:e29367.
44. Semple PL, Binder AB, Davids M, Maredza A, van Zyl-Smit RN, Dheda K. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis. Am J Respir Crit Care Med 2013; 187:1249-1258.
45. Kursar M, Koch M, Mittrucker HW etal. Cutting Edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 2007; 178:2661-2665.
46. Chen X, Zhou B, Li M etal. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 2007; 123:50-59.
47. Marin ND, Paris SC, Velez VM, Rojas CA, Rojas M, Garcia LF. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb) 2010; 90:252-261.
48. de Almeida AS, Fiske CT, Sterling TR, Kalams SA. Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis. Clin Vaccine Immunol 2012; 19:45-52.
49. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2:816-822.
50. Dwyer KM, Hanidziar D, Putheti P etal. Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant 2010; 10:2410-2420.
51. Shafiani S, Dinh C, Ertelt JM etal. Pathogen-specific Treg cells expand early during Mycobacterium tuberculosis infection but are later eliminated in response to interleukin-12. Immunity 2013; 38:1261-1270.
52. Djoba Siawaya JF, Beyers N, van Helden P, Walzl G. Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clin Exp Immunol 2009; 156:69-77.
53. Chiacchio T, Petruccioli E, Vanini V etal. Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLOS ONE 2011; 6:e27539.
54. El Fenniri L, Toossi Z, Aung H etal. Polyfunctional Mycobacterium tuberculosis-specific effector memory CD4+ T cells at sites of pleural TB. Tuberculosis (Edinb) 2011; 91:224-230.